clasto-lactacystin beta-lactone and tapi-2

clasto-lactacystin beta-lactone has been researched along with tapi-2 in 1 studies

Compound Research Comparison

Studies (clasto-lactacystin beta-lactone)	Trials (clasto-lactacystin beta-lactone)	Recent Studies (post-2010) (clasto-lactacystin beta-lactone)	Studies (tapi-2)	Trials (tapi-2)	Recent Studies (post-2010) (tapi-2)
85	0	15	36	1	14

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamik, B; Cui, X; Hawari, FI; Islam, A; Levine, SJ; Liao, DW; Rouhani, FN; Yu, ZX; Zhang, J	1

Other Studies

1 other study(ies) available for clasto-lactacystin beta-lactone and tapi-2

Article	Year
Proteasome inhibition induces TNFR1 shedding from human airway epithelial (NCI-H292) cells. American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 289, Issue:2 Topics: Adenocarcinoma; Apoptosis; Carcinoma, Mucoepidermoid; Cells, Cultured; Cysteine Proteinase Inhibitors; Humans; Hydroxamic Acids; Lactones; Metalloproteases; Proteasome Inhibitors; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor, Type I; Respiratory Mucosa; Respiratory System; Umbilical Veins	2005

Article

Year

Proteasome inhibition induces TNFR1 shedding from human airway epithelial (NCI-H292) cells.

American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 289, Issue:2

Topics: Adenocarcinoma; Apoptosis; Carcinoma, Mucoepidermoid; Cells, Cultured; Cysteine Proteinase Inhibitors; Humans; Hydroxamic Acids; Lactones; Metalloproteases; Proteasome Inhibitors; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor, Type I; Respiratory Mucosa; Respiratory System; Umbilical Veins

2005